Pages that link to "Q72815743"

The following pages link to Differential effects of locally administered clozapine and haloperidol on dopamine efflux in the rat prefrontal cortex and caudate-putamen (Q72815743):

Displaying 33 items.

• Evidence for the preferential involvement of 5-HT2A serotonin receptors in stress- and drug-induced dopamine release in the rat medial prefrontal cortex (Q28567004) (← links)
• Effects of central activation of serotonin 5-HT2A/2C or dopamine D 2/3 receptors on the acute and repeated effects of clozapine in the conditioned avoidance response test (Q30387361) (← links)
• M100,907, a selective 5-HT(2A) antagonist, attenuates dopamine release in the rat medial prefrontal cortex (Q31808081) (← links)
• Heterogeneity of the mesotelencephalic dopamine fibers: physiology and pharmacology (Q33828015) (← links)
• Pharmacology and behavioral pharmacology of the mesocortical dopamine system (Q34104228) (← links)
• Reduction of extracellular dopamine and metabolite concentrations in rat striatum by low doses of acute cyamemazine (Q34178693) (← links)
• On the origin of cortical dopamine: is it a co-transmitter in noradrenergic neurons? (Q34794235) (← links)
• Can antipsychotic drugs be classified by their effects on a particular group of dopamine neurons in the brain? (Q34998394) (← links)
• JL 13, an atypical antipsychotic: a preclinical review. (Q35069583) (← links)
• The medial prefrontal cortex in the rat: evidence for a dorso-ventral distinction based upon functional and anatomical characteristics (Q35576345) (← links)
• Antipsychotic and antidepressive effects of second generation antipsychotics: two different pharmacological mechanisms? (Q36183110) (← links)
• Neurobiology of dopamine in schizophrenia (Q36756356) (← links)
• Dopamine receptor homooligomers and heterooligomers in schizophrenia (Q37242424) (← links)
• In vivo brain microdialysis: advances in neuropsychopharmacology and drug discovery (Q37870701) (← links)
• Development and application of a sensitive high performance ion-exchange chromatography method for the simultaneous measurement of dopamine, 5-hydroxytryptamine and norepinephrine in microdialysates from the rat brain (Q42513139) (← links)
• Chronic clozapine, but not haloperidol, treatment affects rat brain vesicular monoamine transporter 2. (Q43990920) (← links)
• Effects of clozapine on the efflux of serotonin and dopamine in the rat brain: the role of 5-HT1A receptors (Q44300915) (← links)
• Effects of clozapine, haloperidol and iloperidone on neurotransmission and synaptic plasticity in prefrontal cortex and their accumulation in brain tissue: an in vitro study (Q44345714) (← links)
• Co-release of noradrenaline and dopamine from noradrenergic neurons in the cerebral cortex induced by clozapine, the prototype atypical antipsychotic. (Q44359160) (← links)
• Selective antagonism at dopamine D3 receptors enhances monoaminergic and cholinergic neurotransmission in the rat anterior cingulate cortex (Q44362504) (← links)
• Clozapine increases reward evaluation but not overall ingestive behaviour in rats licking for sucrose (Q45760377) (← links)
• Preclinical investigations into the antipsychotic potential of the novel histamine H3 receptor antagonist GSK207040. (Q46397527) (← links)
• Role of different monoamine receptors controlling MK-801-induced release of serotonin and glutamate in the medial prefrontal cortex: relevance for antipsychotic action (Q46407712) (← links)
• Caudate size in first-episode neuroleptic-naive schizophrenic patients measured using an artificial neural network (Q47258226) (← links)
• A preclinical assessment of d.l-govadine as a potential antipsychotic and cognitive enhancer (Q48030532) (← links)
• The atypical antipsychotic sertindole enhances efflux of dopamine and its metabolites in the rat cortex and striatum (Q48260562) (← links)
• Improvement of prefrontal brain function in endogenous psychoses under atypical antipsychotic treatment (Q48319523) (← links)
• In rats chronically treated with clozapine, tyrosine depletion attenuates the clozapine-induced in vivo increase in prefrontal cortex dopamine and norepinephrine levels (Q48616520) (← links)
• Ritanserin administration potentiates amphetamine-stimulated dopamine release in the rat prefrontal cortex (Q48712285) (← links)
• Beneficial effect of atypical antipsychotics on prefrontal brain function in acute psychotic disorders (Q49155679) (← links)
• L-Tyrosine availability affects basal and stimulated catecholamine indices in prefrontal cortex and striatum of the rat. (Q52092911) (← links)
• Xanomeline, an M(1)/M(4) preferring muscarinic cholinergic receptor agonist, produces antipsychotic-like activity in rats and mice. (Q52168809) (← links)
• The role of endogenous sensitization in the pathophysiology of schizophrenia: implications from recent brain imaging studies (Q73553209) (← links)